ATE321525T1 - Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis - Google Patents

Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis

Info

Publication number
ATE321525T1
ATE321525T1 AT00954854T AT00954854T ATE321525T1 AT E321525 T1 ATE321525 T1 AT E321525T1 AT 00954854 T AT00954854 T AT 00954854T AT 00954854 T AT00954854 T AT 00954854T AT E321525 T1 ATE321525 T1 AT E321525T1
Authority
AT
Austria
Prior art keywords
conjugated
linolene
cellulitis
acids
topical treatment
Prior art date
Application number
AT00954854T
Other languages
English (en)
Inventor
Carlo Ghisalberti
Original Assignee
Pentapharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ltd filed Critical Pentapharm Ltd
Application granted granted Critical
Publication of ATE321525T1 publication Critical patent/ATE321525T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/14—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by isomerisation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00954854T 1999-09-09 2000-09-08 Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis ATE321525T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001894A ITMI991894A1 (it) 1999-09-09 1999-09-09 Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso

Publications (1)

Publication Number Publication Date
ATE321525T1 true ATE321525T1 (de) 2006-04-15

Family

ID=11383591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954854T ATE321525T1 (de) 1999-09-09 2000-09-08 Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis

Country Status (13)

Country Link
US (1) US6953583B1 (de)
EP (1) EP1214048B1 (de)
JP (2) JP2003508479A (de)
KR (1) KR100703142B1 (de)
CN (1) CN1157181C (de)
AT (1) ATE321525T1 (de)
AU (3) AU6720500A (de)
BR (1) BR0013897A (de)
CA (1) CA2384028A1 (de)
DE (1) DE60027016T2 (de)
ES (1) ES2261228T3 (de)
IT (1) ITMI991894A1 (de)
WO (3) WO2001017498A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001238363A1 (en) * 2000-02-15 2001-08-27 Zen Bio, Inc. Compositions for preventing cellulite in mammalian skin
US7025984B1 (en) 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
AU2005242170B2 (en) * 2000-06-26 2008-12-18 The Procter & Gamble Company Compositions and methods for body weight management
JP4220247B2 (ja) 2001-03-29 2009-02-04 ビーエーエスエフ ソシエタス・ヨーロピア 共役不飽和グリセリド混合物及びその製造方法
EP1302114A3 (de) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mischungen zur Förderung der Glucoseaufnahme
US6677470B2 (en) * 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
US20040228884A1 (en) * 2003-05-15 2004-11-18 Gupta Shyam K. Ion-pair delivery system for cosmetic and pharmaceutical compositions
DE10317109A1 (de) * 2003-04-14 2004-11-11 Cognis Deutschland Gmbh & Co. Kg Zubereitungen zur oralen Aufnahme
WO2004110396A1 (de) * 2003-06-17 2004-12-23 Dsm Ip Assets B.V. Topisches mittel enthaltend phytansäure oder ein derivat davon
EP1541037A1 (de) * 2003-12-04 2005-06-15 Cognis Deutschland GmbH & Co. KG Zubereitung zur oralen Aufnahme enthaltend Extrakte von Passiflora incarnata
FR2865402B1 (fr) * 2004-01-27 2006-04-28 Inst Phytoceutic Composition amaigrissante par voie orale comprenant de l'acide linoleique conjugue et de la cafeine.
EP1750523B1 (de) * 2004-03-17 2010-07-21 Nestec S.A. Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit
EP1586244A1 (de) * 2004-04-16 2005-10-19 Cognis IP Management GmbH Zubereitungen für die orale Aufnahme
ATE480301T1 (de) 2004-06-15 2010-09-15 Boots Co Plc Haarpflegezusammensetzungen und verfahren
EP1618885A1 (de) * 2004-07-10 2006-01-25 Cognis IP Management GmbH Kosmetische und/oder pharmazeutische Zubereitung enthaltend Fettsäurenfettsäauren und Extrakten von Castanea Sativa
EP1656934A1 (de) * 2004-11-12 2006-05-17 Cognis IP Management GmbH Verwendung von physiologisch aktiven Fettsäuren zur Behandlung von Lipodystrophie
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
EP2368442B1 (de) 2005-07-27 2014-12-17 Symrise AG Verwendung von Hesperetin zur Verstärkung von süßem Geschmack
US8226973B2 (en) 2005-11-02 2012-07-24 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
US7172754B1 (en) 2005-12-23 2007-02-06 Conopco, Inc. Cosmetic emulsions with sunscreens and conjugated linoleic acid
US7175835B1 (en) 2005-12-23 2007-02-13 Conopco, Inc. Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid
US7175836B1 (en) 2005-12-23 2007-02-13 Conopco, Inc. Oil continuous phase cosmetic emulsions with conjugated linoleic acid
US8197859B2 (en) * 2006-04-07 2012-06-12 Kao Corporation Lipolysis stimulator
AU2007238816B2 (en) * 2006-04-10 2012-12-06 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
DE102007009650A1 (de) * 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
JP5165299B2 (ja) * 2007-07-20 2013-03-21 ポーラ化成工業株式会社 皮膚外用剤
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
EP2307001A1 (de) 2008-06-11 2011-04-13 BioChemics, Inc. Kontrolle der blutgefässphysiologie zur behandlung von hauterkrankungen
US9284297B2 (en) 2008-08-11 2016-03-15 President And Fellows Of Harvard College Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
WO2010034019A1 (en) 2008-09-22 2010-03-25 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
PT104241B (pt) * 2008-10-29 2012-03-06 Stargate Produtos Farmaceuticos Dieteticos E Nutricionais Lda Composições incorporando agentes redutores da celulite e inestetismos associados e formulações que as contêm
BRPI0921959A2 (pt) 2008-12-04 2017-05-30 Biochemics Inc métodos e composições para remoção de tatuagem
KR101119877B1 (ko) * 2009-03-03 2012-02-28 (주)에이치케이바이오텍 지방감소를 위한 피부도포용 조성물 및 이것의 제조방법
WO2010112084A1 (en) * 2009-04-03 2010-10-07 Oriflame Cosmetics Sa Topical cosmetic compositions for treating or preventing cellulite
US10052299B2 (en) 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
WO2012148926A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating pufas
EP3730135A1 (de) 2011-04-26 2020-10-28 Retrotope, Inc. Erkrankungen aufgrund gestörter energieverarbeitung und mitochondrienmangel
US10154978B2 (en) * 2011-04-26 2018-12-18 Retrotope, Inc. Disorders implicating PUFA oxidation
EP3689342A1 (de) 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative netzhauterkrankungen
US8809560B2 (en) 2011-05-17 2014-08-19 Board Of Trustees Of The University Of Arkansas Trans-, trans-conjugated linoleic acid compositions and use thereof
DK2802652T3 (da) 2012-01-12 2019-07-15 Endo Global Ventures Clostridium histolyticum enzym
JP2015506363A (ja) 2012-01-13 2015-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用
MX2014009308A (es) * 2012-02-29 2014-10-14 Avon Prod Inc Uso de moduladores de cpt-1 y composiciones de los mismos.
JP6049862B2 (ja) * 2012-09-07 2016-12-21 株式会社 資生堂 フィブリン３及び／又はサルコグリカンγを指標としたセルライトの評価方法及びセルライト効果薬剤の評価方法
US9062276B2 (en) 2012-12-03 2015-06-23 Board Of Trustees Of The University Of Arkansas Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
KR102267689B1 (ko) 2013-03-15 2021-06-22 마리 케이 인코포레이티드 화장품 조성물들 및 이의 용도
CN103385516A (zh) * 2013-07-29 2013-11-13 安徽燕之坊食品有限公司 一种液体补充物
JP2017508003A (ja) * 2014-02-11 2017-03-23 イーエルシー マネージメント エルエルシー ケラチン表面におけるボリュームの外観をモジュレートするための方法、組成物及びキット
US9833393B2 (en) 2015-09-24 2017-12-05 Elc Management Llc Method and compositions for treating skin
US10730821B2 (en) 2015-11-23 2020-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
JP7558654B2 (ja) * 2017-03-01 2024-10-01 エンド ベンチャーズ アンリミテッド カンパニー セルライトを評価及び処置するための装置及び方法
KR20240001279A (ko) 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase
JP2023514711A (ja) 2020-02-21 2023-04-07 レトロトップ、 インコーポレイテッド 多価不飽和脂肪酸及びその誘導体の同位体修飾方法
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255206A (de) * 1959-08-24
CH399431A (fr) * 1962-07-13 1965-09-30 Biorex Laboratories Ltd Procédé de préparation de l'acide 18-alpha-glycyrrhétinique
DE2049937A1 (en) * 1970-10-10 1972-04-13 Rhodium or ruthenium complexes and metal halides - as isomerisation catalysts for conjugated diene prodn
US4164505A (en) * 1977-07-08 1979-08-14 Sylvachem Corporation Flow process for conjugating unconjugated unsaturation of fatty acids
FR2474310A1 (fr) * 1980-01-25 1981-07-31 Oreal Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
US5208356A (en) * 1989-02-17 1993-05-04 Wisconsin Alumni Research Foundation Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
FR2678622B1 (fr) * 1991-07-03 1994-11-18 Adir Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5814663A (en) * 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
JP3452986B2 (ja) * 1994-09-13 2003-10-06 花王株式会社 脂肪分解促進剤
JPH08245403A (ja) * 1995-03-07 1996-09-24 Baker Norton Pharmaceut Inc インシュリン抵抗性症候群治療用組成物
EP0866874B2 (de) * 1995-11-14 2005-06-22 Loders Croklaan B.V. Prozess für die präparation von substanzen mit hohem gehalt an isomeren von konjugierte linölsäure
JP4104180B2 (ja) * 1996-05-08 2008-06-18 一丸ファルコス株式会社 リパーゼ活性促進剤
US5667793A (en) * 1996-08-02 1997-09-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions for treating cellulite
JPH10101546A (ja) * 1996-09-27 1998-04-21 Shiseido Co Ltd 皮膚外用剤
GB9621630D0 (en) 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
JP3017108B2 (ja) * 1996-10-30 2000-03-06 リノール油脂株式会社 共役リノール酸の製造方法
DE19718245C5 (de) * 1997-04-30 2004-11-11 Cognis Deutschland Gmbh & Co. Kg Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
US6136985A (en) * 1997-12-23 2000-10-24 Dcv, Inc. CLA esters and uses thereof
WO1999055326A1 (en) * 1998-04-30 1999-11-04 Vit-Immune, L.C. Method of treatment of glutathione deficient mammals
AU4972599A (en) * 1998-07-07 2000-01-24 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
GB9828379D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin care composition
AU4402600A (en) * 1999-05-18 2000-12-05 Rawlings, Anthony V. Fat containing products
AU2001238363A1 (en) * 2000-02-15 2001-08-27 Zen Bio, Inc. Compositions for preventing cellulite in mammalian skin

Also Published As

Publication number Publication date
DE60027016D1 (de) 2006-05-18
AU6720300A (en) 2001-04-10
EP1214048B1 (de) 2006-03-29
KR20030005156A (ko) 2003-01-17
DE60027016T2 (de) 2006-11-30
ITMI991894A1 (it) 2001-03-09
ITMI991894A0 (it) 1999-09-09
KR100703142B1 (ko) 2007-04-05
BR0013897A (pt) 2002-05-14
JP2003508479A (ja) 2003-03-04
WO2001017374A1 (en) 2001-03-15
EP1214048A1 (de) 2002-06-19
WO2001018161A3 (en) 2001-11-01
WO2001017498A1 (en) 2001-03-15
ES2261228T3 (es) 2006-11-16
US6953583B1 (en) 2005-10-11
AU6720000A (en) 2001-04-10
JP2011063609A (ja) 2011-03-31
AU6720500A (en) 2001-04-10
CN1157181C (zh) 2004-07-14
CN1378441A (zh) 2002-11-06
WO2001018161A2 (en) 2001-03-15
CA2384028A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
FI973492A0 (fi) NO-syntaasin estäjät
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
ATE215366T1 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
DE50312289D1 (de) Verfahren zur Isolierung von mesenchymalen Stammzellen des Haarfollikels
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
ATE394365T1 (de) Verfahren zur synthese von verbindungen vom ceramidtyp
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
EA200700044A1 (ru) Композиция для местного применения
ATE243524T1 (de) Zusammensetzungen enthaltend boswellia-extrakte
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
DE69917858D1 (de) Gebrauch von Silicongummi zur Stabilisierung von Ascorbinsaüre und Vorbereitungen die diese Zusammensetzungen enthalten
DE69731898D1 (de) Verwendung von Sulphoquinovosyldiacylglycerols zur Behandlung von entzündlichen Hauterkrankungen
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA04001289A (es) Composicion cosmetica y metodo para tratar la piel.
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE273991T1 (de) Mit gallensäuren verknüpfte propanolaminderivate zur behandlung von lipidstoffwechselstörungen
EP0744175A3 (de) Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Hydroxyfettsäuren
ATE218877T1 (de) Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1214048

Country of ref document: EP

REN Ceased due to non-payment of the annual fee